Cargando…
Anaphylaxis to three humanized antibodies for severe asthma: a case study
BACKGROUND: Omalizumab, mepolizumab, benralizumab, and dupilumab are the currently available biologics used to treat asthma in Japan. Anaphylaxis following treatment with mepolizumab or benralizumab is considered rare. CASE PRESENTATION: We report the case of a 35-year-old woman with severe asthma,...
Autores principales: | Jingo, Koichi, Harada, Norihiro, Nishioki, Toshihiko, Torasawa, Masahiro, Yamada, Tomoko, Asao, Tetsuhiko, Takagi, Haruhi, Takeshige, Tomohito, Ito, Jun, Takahashi, Kazuhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288423/ https://www.ncbi.nlm.nih.gov/pubmed/32536947 http://dx.doi.org/10.1186/s13223-020-00446-w |
Ejemplares similares
-
Pulmonary Intravascular Large B-cell Lymphoma (IVLBCL) Disguised as an Asthma Exacerbation in a Patient with Asthma
por: Takeshige, Tomohito, et al.
Publicado: (2017) -
MAP3K19 Affects TWEAK-Induced Response in Cultured Bronchial Epithelial Cells and Regulates Allergic Airway Inflammation in an Asthma Murine Model
por: Sandhu, Yuuki, et al.
Publicado: (2023) -
A case of hand urticaria, lip angioedema, and oropharyngeal pruritus induced by Japanese radish through IgE-mediated immediate allergic reaction
por: Abe, Sumiko, et al.
Publicado: (2021) -
Mobile Health App for Japanese Adult Patients With Asthma: Clinical Observational Study
por: Harada, Norihiro, et al.
Publicado: (2020) -
Pretreatment Frequency of Circulating Th17 Cells and FeNO Levels Predicted the Real-World Response after 1 Year of Benralizumab Treatment in Patients with Severe Asthma
por: Sandhu, Yuuki, et al.
Publicado: (2023)